Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... assay in the sera of 104 patients with gynecological cancer including 36 with ovarian, 40 with cervical, and 28 with endometrial cancers. The serum levels of DKK-1 protein ...
2009 NOV 23 ... ovarian cancers. We analyzed a family fulfilling classical criteria of hereditary breast/ovarian cancer." "After complete sequencing of coding regions and splice junctions of ...
2009 NOV 23 ... toxicity profile in breast and lung cancers. Five patients with gynecologic cancers (2 ovarian, 2 endometrial, and I cervical malignancy) received Abraxane after having a ... or major side effects to the drug. Abraxane is well tolerated in women with gynecologic cancer who have experienced a paclitaxel-associated hypersensitivity reaction," wrote A.N. ...
2009 NOV 23 ... results of fertility-sparing surgery in the treatment of early-stage invasive epithelial ovarian cancer. A retrospective review of 123 patients who underwent surgical staging for FIGO stage I ...
2009 NOV 23 ... nonmammary/nongynecologic origin, we conclude that the diagnosis of metastatic breast, ovarian or endometrial carcinoma in a carcinoma of unknown primary should not be based solely on ... frequent expression in breast and gynecologic carcinomas, the National Comprehensive Cancer Network has recommended that the immunohistochemical expression of estrogen (ER) and/or ...
2009 NOV 23 ... using automated clinical data to capture chemotherapy administrations in a cohort of 757 ovarian cancer patients enrolled in 7 health plans in the HMO Cancer Research Network. We calculated ...
2009 NOV 23 ... processes. Our studies show that microRNA-9 (miR-9) is downregulated in human ovarian cancer relative to normal ovary, and overexpression of miR-9 suppresses cell growth in vitro," ...
2009 NOV 27 ... Similar abnormalities in NOTCH also underlie a variety of other cancers, including lung, ovarian, pancreatic and gastrointestinal cancers.Even with this deep scientific ... that could someday be used to treat a variety of diseases, especially multiple types of cancer."There is a pressing need for drugs that target transcription factors, both ...
2009 NOV 23 ... with an improved survival at the expense of increased toxicity in optimally debulked ovarian cancer patients. We describe the toxicity profile of an outpatient regimen of an intravenous ...
2009 NOV 23 ... and antitumor activity in a xenograft model of human ovarian carcinoma,' new data in ovarian cancer. "This study was designed to determine the effects of vandetanib, a small-molecule ...
2009 NOV 23 ... retreatment can be regarded as a standard option in the so-called platinum-sensitive ovarian cancer, but its use can be limited by the occurrence of sometimes severe hypersensitivity ...
2009 NOV 23 ... "Germ cells are sensitive to genotoxins, and ovarian failure and infertility are major side effects of chemotherapy in young patients with ... failure and infertility are major side effects of chemotherapy in young patients with cancer. Here we describe the c-Abl-TAp63 pathway activated by chemotherapeutic DNA-damaging ...
2009 NOV 23 ... Polymeric Micelles Targeting Folate Receptors and Early Endosomal pH in Drug-Resistant Ovarian Cancer. Molecular Pharmaceutics, 2009;6(5):1353-1362). For additional information, ...
2009 NOV 23 ... survival) with a strength that is better than any other prognostic factor in epithelial ovarian cancer including FIGO stage," wrote K.M. Jochumsen and colleagues, Odense University. ...
2009 NOV 23 ... (USPTO) has issued patent number 7,605,003 titled "Use of biomarkers for detecting ovarian cancer" to the Company for the discovery of biomarkers for...
2009 NOV 29 ... later in their life than men: the risk increases after menopause, partly because of ovarian hormone deficiency that favours hypertension, diabetes, hyperlipidemia, central obesity ... women worldwide, killing more than 8.6 million, more than the total number who die from cancer, tuberculosis, HIV/AIDS and malaria combined.However, the risk for women is ...
